Trial
NCT03498196
A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Baylor College of Medicine
Collaborators
Pfizer
Condition
Bladder Cancer
Intervention
Avelumab
Why stopped
The sponsor of this study has terminated the study due to poor enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-08-24